2020
DOI: 10.4236/crcm.2020.912051
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous Angiomyolipoma of the Nose

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Most patients are asymptomatic, presenting only with a visible or palpable nodular lesion with slow growth, ranging from 2 months to 40 years (median 5 years). Some patients experience tumor size fluctuation over time or that associated with environmental temperature changes (clinical manifestation of the vascular component of the tumor) [ 22 , 28 ], pain (probably associated with increased sensitivity due to location or trauma) [ 21 ], and obstructive symptoms related to specific sites (such as nasal cavity) and large tumor size [ 39 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Most patients are asymptomatic, presenting only with a visible or palpable nodular lesion with slow growth, ranging from 2 months to 40 years (median 5 years). Some patients experience tumor size fluctuation over time or that associated with environmental temperature changes (clinical manifestation of the vascular component of the tumor) [ 22 , 28 ], pain (probably associated with increased sensitivity due to location or trauma) [ 21 ], and obstructive symptoms related to specific sites (such as nasal cavity) and large tumor size [ 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…Cutaneous AML was first described by Argenyi et al [ 9 ] in 1986. Since then, according to a comprehensive review of English and Spanish literature (PubMed, SciELO, and Google Scholar) by searching the databases using the terms cutaneous angiomyolipoma and cutaneous angiolipoleiomyoma without date restrictions, 43 patients with cutaneous AML have been reported to date ( Table 1 ) [ 10 - 39 ]. To our knowledge, our case is the 44th case of cutaneous AML described.…”
Section: Introductionmentioning
confidence: 99%